Biomaterials

Syndicate content

New 3-D test method for biomaterials flat out faster

A novel, three-dimensional (3-D) screening method for analyzing interactions between cells and new biomaterials could cut initial search times by more than half, researchers from the National Institute of Standards and Technology (NIST) and Rutgers University report in the new issue of Advanced Materials.

Get the full story...

Researchers build new model of bio-exploration

Two land-grant universities have developed a new approach to global bio-exploration, one that returns most of the fruits of discovery to the countries that provide the raw materials on which the research depends.

Get the full story...

Rutgers biomaterial debuts in clinical trials of new stent

A revolutionary, new biomaterial, developed at the New Jersey Center for Biomaterials (NJCBM) at Rutgers University, has moved from the lab bench to field testing in record time. This achievement, a product of a breakthrough methodology in biomaterials discovery, is the enabling technology behind a coronary stent undergoing its first-in-human clinical trial in Germany and in Brazil.

Get the full story...

New medical implants should react with body

A world leader in medical implants calls for a rethink in our approach to building medical implants.

Get the full story...

Nanotube structures hold potential for creating synthetic tissue, muscles

The ability of carbon nanotubes to withstand repeated stress yet retain their structural and mechanical integrity is similar to the behavior of soft tissue, according to a new study from Rensselaer Polytechnic Institute.

Get the full story...

Cells selectively absorb short nanotubes

DNA-wrapped single-walled carbon nanotubes (SWCNTs) shorter than about 200 nanometers readily enter into human lung cells and so may pose an increased risk to health, according to scientists at the National Institute of Standards and Technology (NIST). The results of their laboratory studies appear in an upcoming issue of Advanced Materials.

Get the full story...

New Biomaterial Joint Venture of Olympus with Terumo

Olympus Corporation (Olympus), Terumo Corporation (Terumo) and Olympus Biomaterial Corp. (OBM), a wholly owned subsidiary of Olympus Corporation, have today agreed to incorporate the new Joint Venture specializing in biomaterials. The new Joint Venture will be launched on April 1, 2007.

Read the full story